Who owns PLUS THERAPEUTICS INC?
- Ticker: PSTV
- CUSIP Number: 72941h509
Tip: Access positions for across all investors
Analyze quarterly positions in Plus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Plus Therapeutics stock
Who bought or sold PLUS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 33k | $59k | 0% | Mar 2024 |
|
| Geode Capital Management | 29k | $53k | 10% | Mar 2024 |
|
| Citadel Advisors | 11k | $19k | -36% | Mar 2024 |
|
| BlackRock | 7.0k | $13k | 0% | Mar 2024 |
|
| Tower Research Capital | 3.8k | $6.9k | 164% | Mar 2024 |
|
| Advisor Group Holdings | 133.00 | $239.998500 | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 100.00 | $181.000000 | 1% | Mar 2024 |
|
| Wells Fargo & Company | 35.00 | $63.000000 | 0% | Mar 2024 |
|
| Group One Trading | 1.00 | $2.000000 | 0% | Mar 2024 |
|
Who sold out of Plus Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Dec 2023 | 8.9k | $16k |